Ablative Solutions
Ablative Solutions investigates alcohol-mediated renal denervation using the Peregrine System Kit to reduce high blood pressure in patients with hypertension.
Company Overview
Ablative Solutions specializes in investigating alcohol-mediated renal denervation to reduce high blood pressure in patients with hypertension. The company focuses on using the Peregrine System Kit, an investigational product designed to evaluate efficacy and safety in treating patients with uncontrolled hypertension.
Peregrine System Kit
The Peregrine System Kit is an investigational medical product used in the treatment of uncontrolled hypertension. It is specifically designed to deliver a neurolytic solution into the perivascular space of the renal artery, ablating nerves that influence blood pressure regulation. Ablative Solutions is currently studying its efficacy and safety through multiple clinical trials, including the TARGET BP Clinical Trial program.
Peregrine Procedure
The Peregrine Procedure is performed using the Peregrine System Kit. It involves delivering a neurolytic solution into the perivascular space of the renal artery to ablate nerves that affect blood pressure regulation. This procedure is part of current investigations to determine its potential in reducing high blood pressure in patients with hypertension.
TARGET BP Clinical Trial Program
The TARGET BP Clinical Trial program is an initiative by Ablative Solutions aimed at assessing the efficacy and safety of renal denervation using the Peregrine System Kit. Among the trials within this program is the TARGET BP I clinical trial (NCT02910414), which specifically evaluates the safety and effectiveness of the Peregrine System Kit in treating patients with uncontrolled hypertension.
TARGET BP I Clinical Trial
The TARGET BP I clinical trial (NCT02910414) is a part of the TARGET BP Clinical Trial program conducted by Ablative Solutions. This trial assesses the efficacy and safety of renal denervation using the investigational Peregrine System Kit. It is focused on determining how well this procedure can reduce high blood pressure in patients with uncontrolled hypertension.